Leukemia
Showing 7976 - 8000 of 9,158
Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, AIDS-related Peripheral/Systemic Lymphoma Trial
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +80 more
- imatinib mesylate
- pharmacological study
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Feb 6, 2013
Leukemia Trial in East Hanover (imatinib mesylate)
Completed
- Leukemia
- imatinib mesylate
-
East Hanover, New JerseyNovartis Pharmaceuticals Corporation
Jan 16, 2013
Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Houston (bevacizumab,
Terminated
- Blastic Phase Chronic Myelogenous Leukemia
- Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- bevacizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Terminated
- Recurrent Adult Diffuse Large Cell Lymphoma
- +2 more
- temsirolimus
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Jan 23, 2013
Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia Trial in Geneva (raltitrexed)
Completed
- Recurrent Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood Acute Myeloid Leukemia
-
Geneva, SwitzerlandSwiss Pediatric Oncology Group - Geneva
Jan 15, 2013
Mucinous Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Colon, Stage IIA Colon Cancer Trial in Chicago
Completed
- Mucinous Adenocarcinoma of the Colon
- +4 more
- edrecolomab
- laboratory biomarker analysis
-
Chicago, IllinoisCancer and Leukemia Group B
Jun 4, 2013
Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma Trial in Chicago, Boston (sorafenib
Completed
- Epithelial Mesothelioma
- +7 more
- sorafenib tosylate
- laboratory biomarker analysis
-
Chicago, Illinois
- +1 more
Jun 4, 2013
Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Transitional Cell Cancer of the Renal Pelvis and
Completed
- Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
- Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
- gemcitabine hydrochloride
- +3 more
-
Chicago, IllinoisCancer and Leukemia Group B
Jun 4, 2013
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Chicago (drug, biological,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- estramustine phosphate sodium
- +3 more
-
Chicago, IllinoisCancer and Leukemia Group B
Jun 4, 2013
Cancer Trial in Hershey (biological, genetic, other)
Unknown status
- Cancer
- cytomegalovirus IE-1-specific cytotoxic T lymphocytes
- +6 more
-
Hershey, PennsylvaniaPenn State Cancer Institute at Milton S. Hershey Medical Center
Dec 17, 2013
Cord Blood Stem Cell Transplantation, Hematologic Malignancies Trial in United States (Cord blood transplantation)
Completed
- Cord Blood Stem Cell Transplantation
- Hematologic Malignancies
- Cord blood transplantation
-
Duarte, California
- +9 more
Mar 7, 2014
Rapid Profiling of Bone Marrow, at Presentation and After 5 Days
Unknown status
- AML
-
Haifa, IsraelRambam medical center
May 5, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Chronic Phase Chronic Myelogenous
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +6 more
- PR1 leukemia peptide vaccine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 4, 2013
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Rochester (cediranib maleate, laboratory
Completed
- B-cell Chronic Lymphocytic Leukemia
- Refractory Chronic Lymphocytic Leukemia
- cediranib maleate
- laboratory biomarker analysis
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Jan 14, 2013
Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia,
Terminated
- Accelerated Phase Chronic Myelogenous Leukemia
- +4 more
- imatinib mesylate
- +2 more
-
Orange, CaliforniaUniversity of California Medical Center At Irvine-Orange Campus
Jan 11, 2013
Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a)
Completed
- Childhood Acute Erythroleukemia (M6)
- +15 more
- asparaginase
- +15 more
-
Arcadia, CaliforniaChildren's Oncology Group
Jan 15, 2013
MALT, Nodal Marginal Zone B-cell Lymphoma, Prolymphocytic Leukemia Trial in New York (arsenic trioxide, laboratory biomarker
Terminated
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +10 more
- arsenic trioxide
- laboratory biomarker analysis
-
New York, New YorkMount Sinai Medical Center
Jan 31, 2013
Invasive Fungal Infections, Invasive Aspergillosis, Invasive Fusariosis Trial in Rio de Janeiro (caspofungin as preemptive
Terminated
- Invasive Fungal Infections
- +2 more
- caspofungin as preemptive antifungal therapy
-
Rio de Janeiro, RJ, BrazilUniv. Fed. Rio de Janeiro
Jan 28, 2014
Hyper-CVAD Treatment in Lymphoblastic Lymphoma
Unknown status
- Lymphoblastic Lymphoma
-
Suwon, Kyeonggi, Korea, Republic ofAjou Universtiy School of Medicine
Mar 14, 2013
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +14 more
-
Baltimore, MarylandJohns Hopkins University
Jan 8, 2013
Intracellular and Plasma Imatinib Levels in Chronic Myeloid
Completed
- Chronic Myeloid Leukemia
-
Hamilton, Ontario, CanadaJuravinski Cancer Centre
Jan 10, 2013
Leukemia Trial in Los Angeles (dasatinib)
Completed
- Leukemia
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jan 7, 2013
Leukemia, Lymphoma Trial in Buffalo (aminolevulinic acid HCl)
Completed
- Leukemia
- Lymphoma
- aminolevulinic acid hydrochloride
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 30, 2013